Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
Fig. 6 A
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 6 B
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 7 C
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 A
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 B
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 C
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 D
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 E,F
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 8 G,H,I
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization) |
|
||||
Fig. 6 D
Sullivan CH et al. (2019) |
Xla Wt + irx1
NF 24- NF 28 (in situ hybridization) |
|